Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Express Scripts
Johnson and Johnson
Dow
AstraZeneca

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076266

See Plans and Pricing

« Back to Dashboard

NDA 076266 describes DOXAPRAM HYDROCHLORIDE, which is a drug marketed by Athenex Inc and Watson Labs and is included in two NDAs. Additional details are available on the DOXAPRAM HYDROCHLORIDE profile page.

The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the doxapram hydrochloride profile page.
Summary for 076266
Tradename:DOXAPRAM HYDROCHLORIDE
Applicant:Athenex Inc
Ingredient:doxapram hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 076266

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Jan 10, 2003TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Mallinckrodt
McKinsey
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.